解锁成功:预防和管理慢性全闭塞并发症的策略 皮肤冠状动脉干预程序
Reza Masoomi1, Kathleen E Kearney1, Rhian E Davies2
1Division of Cardiology, University of Washington, Seattle, Washington.
The American journal of cardiology
|September 14, 2024
概括
经皮冠状动脉干预 (PCI) 的并发症管理,特别是慢性全闭症 (CTO) 病例,需要专注于预防和准备. 从并发症中学习可以提高患者的安全性,并推进CTO PCI实践.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管外科心血管外科
背景情况:
- 慢性全闭性冠状动脉干预 (PCI) 对慢性全闭性冠状动脉干预 (CTO) 存在重大挑战.
- 在CTO PCI期间出现的并发症,如穿孔和吸管,导致0.4%的住院死亡率.
研究的目的:
- 概述一个框架来管理CTO PCI中的并发症.
- 强调预防,准备和从不良事件中学习.
主要方法:
- 坚持"三P"框架:预防,准备和规划.
- 确保全面的患者讨论和遵守适当性使用标准.
- 保持一个训练有素的团队,使用标准化的设备.
主要成果:
- 确定了特定的CTO PCI并发症,包括捐赠器损伤,设备丢失/陷入困境,辐射损伤和冠状动脉穿孔.
- 强调了风险评估工具对于评估围绕程序风险的重要性.
- 他强调了从并发症中提取见解以实现持续改进的价值.
结论:
- 专注于预防和准备的积极方法对于管理CTO PCI并发症至关重要.
- 从并发症中不断学习对于推进CTO PCI实践和改善患者治疗结果至关重要.
- 有效的管理涉及患者沟通,团队培训和标准化的协议.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...


